Hyperpigmentation treatment cream and serum
AssigneeProCell Therapies, LLC
InventorMitchell Schwartz
Life of this patent
Estimating the term…
Abstract
Compositions for skin creams and serums are provided for treating skin hyperpigmentation, the compositions including cysteamine, tranexamic acid, niacinamide, tetrapeptide 30, DNA repair enzymes, and human growth factors. A formulation for the skin cream or serum includes 5% cysteamine by weight, 5% tranexamic acid by weight, 4% niacinamide by weight, 1% tetrapeptide 30 by weight, in which the tetrapeptide 30 includes the following four amino acids linked together: L-prolyl-L-lysyl-L-alpha-glutamyl-L-lysine. In addition, the cream or serum includes DNA repair enzymes, including 1% phytosomes, 0.3 to 1% roxisomes, and 1% ultrasomes. Further, the composition may include recombinant human growth factors.
Claims2
A composition for treating skin hyperpigmentation consisting of:
- about 5 wt % tranexamic acid;
- about 4 wt % niacinamide;
- about 0.20 wt % phytic acid;
- about 5 wt % cysteamine hydrochloride;
- about 1 wt % plankton extract;
- about 1 wt % lecithin;
- about 1 wt % Arabidopsis thaliana extract;
- about 1 wt % micrococcus lysate;
- about 0.01 wt % of one or more recombinant human growth factors selected from the group consisting of sh-polypeptide-62, sh-polypeptide-1, sh-polypeptide-11, sh-polypeptide-31, acetyl octapeptide-17 amide, sh-oligopeptide-2, sh-polypeptide-10, and acetyl sh-oligopeptide-77;
- about 1 wt % tetrapeptide-30;
- about 60 wt % base solvent;
- about 7 wt % emulsifiers;
- about 2 wt % emollients;
- about 6.2 wt % skin moisturizing compounds;
- about 5 wt % emulsion thickeners;
- about 2 wt % odor masking agents;
- about 0.1 wt % chelating agents;
- and
- about 1 wt % preservatives.
Dependencies are inferred from the claim text.